Esma Saâda

Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial

Antoîne Italiano, Olivier Mir, Simone Mathoulin‐Pélissier et al. · The Lancet Oncology · 2020 · 306 citations · Full text

Surgical Oncology, Advanced Ewing Sarcoma, Medicine +5

Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study

Florence Duffaud, Olivier Mir, Pascaline Boudou‐Rouquette et al. · The Lancet Oncology · 2018 · 304 citations

Oncology, Adult Patients, Metronomic Therapy +8

Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group

Maud Toulmonde, Sylvie Bonvalot, Pierre Méeus et al. · Annals of Oncology · 2014 · 202 citations · Full text

Surgical Oncology, Multicenter Analysis, Surgical Pathology +4

Pazopanib or methotrexate–vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study

Maud Toulmonde, Marina Pulido, Isabelle Ray‐Coquard et al. · The Lancet Oncology · 2019 · 193 citations · Full text

Oncology, Combination Chemotherapy, Metronomic Therapy +8

Retroperitoneal sarcomas: patterns of care in advanced stages, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group

Maud Toulmonde, Sylvie Bonvalot, Isabelle Ray‐Coquard et al. · Annals of Oncology · 2014 · 163 citations · Full text